期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (4)
Purpose of review Cardiovascular disease is the most common cause of morbidity and mortality worldwide, and the risk is heightened in the presence of ......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (4)
Purpose of review Enabled by widespread technological advancements, electronic health (eHealth) strategies have expanded rapidly over the last decade,......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (5)
Purpose of review Ultrasound enhancing agents (UEAs), microbubbles which are composed of lipid or albumin shells containing high molecular weight gase......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (5)
Purpose of review The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mostly uses the angiotensin-converting enzyme 2 (ACE-2) as cellular......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (3)
Purpose of review In this review, we critically address the role of epigenetic processing and its therapeutic modulation in heart failure with preserv......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (4)
Purpose of review Atherosclerosis, characterized by lipid accumulation and chronic inflammation in the arterial wall, is the leading causes of death w......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (6)
Purpose of Review The recent American College of Cardiology/American Heart Association/Society for Cardiovascular Angiography and Interventions Guidel......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (6)
Purpose of review Coronary artery disease (CAD) is responsible for >50% of heart failures cases. Patients with ischemic left ventricular systolic d......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (3)
Purpose of the review Thoracic aortic aneurysms and dissections (TAADs) are a major health problem in the Western population. This review summarises r......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (3)
Purpose of review The burden of clinical heart failure, both heart failure with a reduced ejection fraction (HFrEF) and with a preserved ejection frac......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (4)
Purpose of review Recent advances in oncologic therapies have significantly improved overall survival for patients with malignancy. However, cardiovas......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (3)
Purpose of review The goal of this review is to summarize the current knowledge on the role of medical management of cardiogenic shock in the era of m......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (5)
Purpose of review Hypertension (HTN) remains the most common and strongest contributing factor to the development of heart failure with preserved ejec......
期刊： CURRENT OPINION IN CARDIOLOGY, 2022; 37 (6)
Purpose of review Left ventricular assist devices (LVADs) are life-saving therapies for patients in end-stage heart failure (HF) with reduced ejection......
